Efficacy and Safety of Bisphosphonate Therapy in Children with Osteogenesis Imperfecta: A Systematic Review

Publisher： Karger

E-ISSN： 1663-2826|84|1|26-42

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.84, Iss.1, 2015-05, pp. : 26-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 3, 2015-02 ,pp. : 183-189

Karger

Access to resources Recommend Favorite

The Efficacy and Safety of Growth Hormone Therapy in Children with Noonan Syndrome: A Review of the Evidence

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 3, 2014-12 ,pp. : 157-166

Karger

Access to resources Recommend Favorite

Zoledronic Acid Treatment in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 5, 2011-02 ,pp. : 346-353

Karger

Access to resources Recommend Favorite

Fracture during Intravenous Bisphosphonate Treatment in a Child with Osteogenesis Imperfecta: An Argument for a More Frequent, Low-Dose Treatment Regimen

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 3, 2013-12 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Pamidronate Treatment of Children with Moderate-to-Severe Osteogenesis Imperfecta: A Note of Caution

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2008-11 ,pp. : 38-44

Karger

Access to resources Recommend Favorite